4,125 results on '"Robin, A"'
Search Results
2. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study
3. Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial
4. Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
5. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies
6. Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study
7. How I treat adult Ph+ ALL
8. Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
9. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
10. HOXA9 forms a repressive complex with nuclear matrix–associated protein SAFB to maintain acute myeloid leukemia
11. Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities
12. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study
13. Dietary methionine starvation impairs acute myeloid leukemia progression
14. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis
15. Formation of neutrophil extracellular traps requires actin cytoskeleton rearrangements
16. Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS
17. A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
18. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia
19. Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphoma
20. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
21. Plateletpheresis-associated lymphopenia in frequent platelet donors
22. Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Vrd Alone in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Eligible for Autologous Stem Cell Transplantation (ASCT): Primary Results of the Perseus Trial
23. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL
24. Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease
25. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins
26. Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
27. Management of ALL in adults: 2024 ELN recommendations from a European expert panel
28. Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
29. Nonclassical FCGR2C haplotype is associated with protection from red blood cell alloimmunization in sickle cell disease
30. Diffuse large B-cell lymphoma genotyping on the liquid biopsy
31. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
32. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel
33. Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis
34. Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL
35. Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study
36. Preliminary Safety and Efficacy of Bgb-11417, a Novel Bcl-2 Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)
37. Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study
38. Health-Related Quality of Life for Frail Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide and Dexamethasone: Subgroup Analysis of MAIA Trial
39. Procoagulant platelet activation promotes venous thrombosis
40. Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease
41. Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency
42. CBFβ-SMMHC creates aberrant megakaryocyte-erythroid progenitors prone to leukemia initiation in mice
43. The genetics of nodal marginal zone lymphoma
44. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
45. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
46. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
47. Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII
48. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation
49. Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease
50. Updated Results from an Open-Label Phase 1/2 Study of Favezelimab (anti-LAG-3) Plus Pembrolizumab in Relapsed or Refractory Classical Hodgkin Lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.